公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Neuroglobin boosts axon regeneration during ischemic reperfusion via p38 binding and activation depending on oxygen signal	6	Cell Death Dis
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	A Small Molecule Inhibitor of Erg251 Makes Fluconazole Fungicidal by Inhibiting the Synthesis of the 14α-Methylsterols	6	Mbio
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota	4	Toxicology and Applied Pharmacology
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Phage-free peptide ELISA for ochratoxin A detection based on biotinylated mimotope as a competing antigen	5	Talanta
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5	9	Pharmacological Research
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	MYH1G-AS is a chromatin-associated lncRNA that regulates skeletal muscle development in chicken	8	Cellular & Molecular Biology Letters
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	FOXA transcriptional factor modulates insect susceptibility to Bacillus thuringiensis Cry1Ac toxin by regulating the expression of toxin-receptor ABCC2 and ABCC3 genes	1	Insect Biochem Mol Biol
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator	2	Oncology Letters
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma	4	BMC cancer
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma	4	BMC cancer

首页上一页 20 21 22 23 24 25 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部